12
0
0
Like?
Please wait...
About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
How do chemical exposures trigger autoimmune diseases?
The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...
Synthesis of a Kidney Cancer Drug
We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...
Managing Life with Chronic Urine Leakage and Stigma: What Do Women in Ghana Think About an Innovation to Support Coping?
Women with obstetric fistula experience chronic leaking urine, leading to stigma, isolation, and loss of...